Advanced Search

Project: CEV SNA

Public Report Complete



Project Summary

Title and Description


Key Questions


Associated Extraction Forms

Title Created by Key Questions Addressed Form Notes
CEV SNA Data Abstraction Form for Trials Ian Saldanha 1


Associated Studies (each link opens a new tab)

Title Author Year
Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Teikari JM., Laatikainen L., Virtamo J., Haukka J., Rautalahti M., Liesto K., Albanes D., Taylor P., Heinonen OP. 1998
Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians. Christen WG., Manson JE., Glynn RJ., Gaziano JM., Chew EY., Buring JE., Hennekens CH. 2007
Vitamin E supplementation and macular degeneration: randomised controlled trial. Taylor HR., Tikellis G., Robman LD., McCarty CA., McNeil JJ. 2002
Vitamin E and age-related macular degeneration in a randomized trial of women. Christen WG., Glynn RJ., Chew EY., Buring JE. 2010
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. -- Not Found -- 2001
Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial. Bartlett HE., Eperjesi F. 2007
Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study. Piermarocchi S., Saviano S., Parisi V., Tedeschi M., Panozzo G., Scarpa G., Boschi G., Lo Giudice G. 2012
Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Weigert G., Kaya S., Pemp B., Sacu S., Lasta M., Werkmeister RM., Dragostinoff N., Simader C., Garhöfer G., Schmidt-Erfurth U., Schmetterer L. 2011
Oral zinc in macular degeneration. Newsome DA., Swartz M., Leone NC., Elston RC., Miller E. 1988
A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration. Newsome DA. 2008
Oral zinc and the second eye in age-related macular degeneration. Stur M., Tittl M., Reitner A., Meisinger V. 1996
Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy. Garrett SK., McNeil JJ., Silagy C., Sinclair M., Thomas AP., Robman LP., McCarty CA., Tikellis G., Taylor HR. 1999
Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Richer S., Stiles W., Statkute L., Pulido J., Frankowski J., Rudy D., Pei K., Tsipursky M., Nyland J. 2004
Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial. Complications of Age-Related Macular Degeneration Prevention Trial Research Group 2006
Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. Ho AC., Maguire MG., Yoken J., Lee MS., Shin DS., Javornik NB., Fine SL. 1999
Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study. Owens SL., Bunce C., Brannon AJ., Xing W., Chisholm IH., Gross M., Guymer RH., Holz FG., Bird AC. 2006
Laser photocoagulation for macular soft drusen. Updated results. Figueroa MS., Regueras A., Bertrand J., Aparicio MJ., Manrique MG. 1997
Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications. Frennesson C., Nilsson SE. 1998
Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. D'Amico DJ., Goldberg MF., Hudson H., Jerdan JA., Krueger DS., Luna SP., Robertson SM., Russell S., Singerman L., Slakter JS., Yannuzzi L., Zilliox P. 2003
Prophylactic laser treatment of soft drusen maculopathy: a prospective, randomized Nordic study. Frennesson CI., Bek T., Jaakkola A., Nilsson SE. 2009
Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Olk RJ., Friberg TR., Stickney KL., Akduman L., Wong KL., Chen MC., Levy MH., Garcia CA., Morse LS. 1999
Indirect scatter laser photocoagulation to subfoveal choroidal neovascularization in age-related macular degeneration. Arnold J., Algan M., Soubrane G., Coscas G., Barreau E. 1997
Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Dowler JG., Hykin PG., Hamilton AM. 2000
Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ahmadieh H., Shoeibi N., Entezari M., Monshizadeh R. 2009
The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy. Ahn J., Woo SJ., Chung H., Park KH. 2011
Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study. Cheema RA., Al-Mubarak MM., Amin YM., Cheema MA. 2009
Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy. Cho WB., Moon JW., Kim HC. 2010
Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. di Lauro R., De Ruggiero P., di Lauro R., di Lauro MT., Romano MR. 2010
Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients. Friberg TR., Brennen PM., Freeman WR., Musch DC. 2009
Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients. Friberg TR., Musch DC., Lim JI., Morse L., Freeman W., Sinclair S. 2006
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. Age-Related Eye Disease Study 2 Research Group 2013
Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study. Souied EH., Delcourt C., Querques G., Bassols A., Merle B., Zourdani A., Smith T., Benlian P. 2013
Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. -- Not Found -- 2013
Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group. -- Not Found -- 1997
A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation. Bergink GJ., Hoyng CB., van der Maazen RW., Vingerling JR., van Daal WA., Deutman AF. 1998
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Gillies MC., Simpson JM., Luo W., Penfold P., Hunyor AB., Chua W., Mitchell P., Billson F. 2003
Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Slakter JS., Bochow TW., D'Amico DJ., Marks B., Jerdan J., Sullivan EK., Robertson SM., Slakter JS., Sullins G., Zilliox P. 2006
Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy. El-Batarny AM. 2008
Ranibizumab versus verteporfin for neovascular age-related macular degeneration. Brown DM., Kaiser PK., Michels M., Soubrane G., Heier JS., Kim RY., Sy JP., Schneider S. 2006
Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration. Apte RS., Modi M., Masonson H., Patel M., Whitfield L., Adamis AP. 2007
Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Bressler NM., Bressler SB., Childs AL., Haller JA., Hawkins BS., Lewis H., MacCumber MW., Marsh MJ., Redford M., Sternberg P., Thomas MA., Williams GA. 2004
Quality of life in patients with age-related macular degeneration: results from the VISION study. Leys A., Zlateva G., Shah SN., Patel M. 2008
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Heier JS., Boyer DS., Ciulla TA., Ferrone PJ., Jumper JM., Gentile RC., Kotlovker D., Chung CY., Kim RY. 2006
Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naı¨ve proliferative and severe nonproliferative diabetic retinopathy Benjamin J. Ernst,1 Gerardo Garcı´a- Aguirre,2 Scott C. N. Oliver,3 Jeffrey L. Olson,3 Naresh Mandava,3 and Hugo Quiroz-Mercado1 2012
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Chang TS., Bressler NM., Fine JT., Dolan CM., Ward J., Klesert TR. 2007
Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial. Bressler NM., Maguire MG., Murphy PL., Alexander J., Margherio R., Schachat AP., Fine SL., Stevens TS., Bressler SB. 1996
Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage. Farahvash MS., Majidi AR., Roohipoor R., Ghassemi F. -- Not Found --
Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy. González VH., Giuliari GP., Banda RM., Guel DA. 2009
Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial. Mirshahi A., Roohipoor R., Lashay A., Mohammadi SF., Abdoallahi A., Faghihi H. -- Not Found --
Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial. Mirshahi A., Roohipoor R., Lashay A., Mohammadi SF., Abdoallahi A., Faghihi H. -- Not Found --
Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy. Filho JA., Messias A., Almeida FP., Ribeiro JA., Costa RA., Scott IU., Jorge R. 2011
Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Rizzo S., Genovesi-Ebert F., Di Bartolo E., Vento A., Miniaci S., Williams G. 2008
Argon green vs krypton red laser photocoagulation of extrafoveal choroidal neovascular lesions. One-year results in age-related macular degeneration. The Canadian Ophthalmology Study Group. -- Not Found -- 1993
Grid laser treatment of occult choroidal neovascularization in age related macular degeneration. Cardillo Piccolino F., Ghiglione D., Allegri P. 1993
Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Results of a randomized clinical trial. Coscas G., Soubrane G., Ramahefasolo C., Fardeau C. 1991
Treatment of senile disciform macular degeneration: a single-blind randomised trial by argon laser photocoagulation. The Moorfields Macular Study Group. -- Not Found -- 1982
Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. -- Not Found -- 1982
Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. -- Not Found -- 1990
Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. -- Not Found -- 1991
Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. -- Not Found -- 1991
Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. Bressler NM., Bressler SB., Hawkins BS., Marsh MJ., Sternberg P., Thomas MA. 2000
Argon laser treatment of pigment epithelial detachments and of subretinal neovascular membranes in Junius-Kuhnt's senile disciform macular degeneration. A prospective, randomized study. Versteeg-Tijmes NT., de Jong PT., Bos PJ., Bakker D., Greve EL., Oosting J., Nagelkerke NJ., vd Horst-Breetveld HM. 1982
Treatment of neovascular senile maculopathy at the foveal capillary free zone with red krypton laser. Yassur Y., Axer-Siegel R., Cohen S., Svetliza E., Ben-Sira I. 1982
Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1. Sohn EH., He S., Kim LA., Salehi-Had H., Javaheri M., Spee C., Dustin L., Hinton DR., Eliott D. 2012
Intravitreal Avastin as an adjunct in patients with proliferative diabetic retinopathy undergoing pars plana vitrectomy. Zaman Y., Rehman AU., Memon AF. 2013
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Schrier RW., Estacio RO., Esler A., Mehler P. 2002
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Estacio RO., Jeffers BW., Gifford N., Schrier RW. 2000
Effects of medical therapies on retinopathy progression in type 2 diabetes. Chew EY., Ambrosius WT., Davis MD., Danis RP., Gangaputra S., Greven CM., Hubbard L., Esser BA., Lovato JF., Perdue LH., Goff DC., Cushman WC., Ginsberg HN., Elam MB., Genuth S., Gerstein HC., Schubart U., Fine LJ. 2010
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Beulens JW., Patel A., Vingerling JR., Cruickshank JK., Hughes AD., Stanton A., Lu J., McG Thom SA., Grobbee DE., Stolk RP. 2009
Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trial. Ruggenenti P., Iliev I., Filipponi M., Tadini S., Perna A., Ganeva M., Ene-Iordache B., Cravedi P., Trevisan R., Bossi A., Remuzzi G. 2010
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Ruggenenti P., Lauria G., Iliev IP., Fassi A., Ilieva AP., Rota S., Chiurchiu C., Barlovic DP., Sghirlanzoni A., Lombardi R., Penza P., Cavaletti G., Piatti ML., Frigeni B., Filipponi M., Rubis N., Noris G., Motterlini N., Ene-Iordache B., Gaspari F., Perna A., Zaletel J., Bossi A., Dodesini AR., Trevisan R., Remuzzi G. 2011
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Chaturvedi N., Sjolie AK., Stephenson JM., Abrahamian H., Keipes M., Castellarin A., Rogulja-Pepeonik Z., Fuller JH. 1998
Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study. Pradhan R., Fong D., March C., Jack R., Rezapour G., Norris K., Davidson MB. -- Not Found --
Renal and retinal effects of enalapril and losartan in type 1 diabetes. Mauer M., Zinman B., Gardiner R., Suissa S., Sinaiko A., Strand T., Drummond K., Donnelly S., Goodyer P., Gubler MC., Klein R. 2009
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Gaede P., Vedel P., Parving HH., Pedersen O. 1999
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. -- Not Found -- 1998
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. -- Not Found -- 1991
Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser. Hercules BL., Gayed II., Lucas SB., Jeacock J. 1977
Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy. Sato Y., Kojimahara N., Kitano S., Kato S., Ando N., Yamaguchi N., Hori S. 2012
Optic disc neovascularisation in diabetic retinopathy: II. Natural history and results of photocoagulation treatment. Yassur Y., Pickle LW., Fine SL., Singerman L., Orth DH., Patz A. 1980
The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Gritz DC., Srinivasan M., Smith SD., Kim U., Lietman TM., Wilkins JH., Priyadharshini B., John RK., Aravind S., Prajna NV., Duraisami Thulasiraj R., Whitcher JP. 2006
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. -- Not Found -- 2001
Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements. Teikari JM., Rautalahti M., Haukka J., Järvinen P., Hartman AM., Virtamo J., Albanes D., Heinonen O. 1998
A randomized trial of beta carotene and age-related cataract in US physicians. Christen WG., Manson JE., Glynn RJ., Gaziano JM., Sperduto RD., Buring JE., Hennekens CH. 2003
Age-related cataract in a randomized trial of vitamins E and C in men. Christen WG., Glynn RJ., Sesso HD., Kurth T., MacFadyen J., Bubes V., Buring JE., Manson JE., Gaziano JM. 2010
The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Chylack LT., Brown NP., Bron A., Hurst M., Köpcke W., Thien U., Schalch W. 2002
Vitamin E supplementation and cataract: randomized controlled trial. McNeil JJ., Robman L., Tikellis G., Sinclair MI., McCarty CA., Taylor HR. 2004
Vitamin E and age-related cataract in a randomized trial of women. Christen WG., Glynn RJ., Chew EY., Buring JE. 2008
Outcomes and costs of outpatient and inpatient cataract surgery: a randomised clinical trial. Castells X., Alonso J., Castilla M., Ribó C., Cots F., Antó JM. 2001
Postoperative inflammation: extracapsular cataract extraction versus phacoemulsification. Chee SP., Ti SE., Sivakumar M., Tan DT. 1999
Comparison of endothelial cell loss and surgically induced astigmatism following conventional extracapsular cataract surgery, manual small-incision surgery and phacoemulsification. George R., Rupauliha P., Sripriya AV., Rajesh PS., Vahan PV., Praveen S. 2005
Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project. -- Not Found -- 1995
Safety and efficacy of phacoemulsification compared with manual small-incision cataract surgery by a randomized controlled clinical trial: six-week results. Gogate PM., Kulkarni SR., Krishnaiah S., Deshpande RD., Joshi SA., Palimkar A., Deshpande MD. 2005
Comparing phacoemulsification and extracapsular cataract extraction in eyes with pseudoexfoliation syndrome, small pupil, and phacodonesis. Katsimpris JM., Petropoulos IK., Apostolakis K., Feretis D. 2004
Randomised controlled trial of anterior-chamber intraocular lenses. Hennig A., Evans JR., Pradhan D., Johnson GJ., Pokhrel RP., Gregson RM., Hayes R., Wormald RP., Foster A. 1997
Ultrasound biomicroscopy examination of intraocular lens haptic position after phacoemulsification with continuous curvilinear capsulorhexis and extracapsular cataract extraction with linear capsulotomy. Landau IM., Laurell CG. 1999
Randomized study of the blood-aqueous barrier reaction after phacoemulsification and extracapsular cataract extraction. Laurell CG., Zetterström C., Philipson B., Syrén-Nordqvist S. 1998
Effect of cataract surgery on the corneal endothelium: modern phacoemulsification compared with extracapsular cataract surgery. Bourne RR., Minassian DC., Dart JK., Rosen P., Kaushal S., Wingate N. 2004
The Madurai Intraocular Lens Study. II: Clinical outcomes. Prajna NV., Chandrakanth KS., Kim R., Narendran V., Selvakumar S., Rohini G., Manoharan N., Bangdiwala SI., Ellwein LB., Kupfer C. 1998
Cataract surgery: interim results and complications of a randomised controlled trial. Oxford Cataract Treatment and Evaluation Team (OCTET). -- Not Found -- 1986
Extracapsular cataract surgery compared with manual small incision cataract surgery in community eye care setting in western India: a randomised controlled trial. Gogate PM., Deshpande M., Wormald RP., Deshpande R., Kulkarni SR. 2003
Corneal endothelial function after extracapsular cataract extraction and phacoemulsification. Ravalico G., Tognetto D., Palomba MA., Lovisato A., Baccara F. 1997
Cost analysis of cataract surgery with intraocular lens implantation: a single blind randomised clinical trial comparing extracapsular cataract extraction and phacoemulsification. Rizal AM., Aljunid SM., Normalina M., Hanom AF., Chuah KL., Suzainah Y., Zainal M., Azman AB. 2003
The South Asian cataract management study: complications, vision outcomes, and corneal endothelial cell loss in a randomized multicenter clinical trial comparing intracapsular cataract extraction with and without anterior chamber intraocular lens implantation. Snellingen T., Shrestha JK., Huq F., Husain R., Koirala S., Rao GN., Pokhrel RP., Kolstad A., Upadhyay MP., Apple DJ., Arnesen E., Cheng H., Olsen EG., Vogel M. 2000
A comparison of anterior and posterior chamber lenses after cataract extraction in rural Africa: a within patient randomised trial. Waddell KM., Reeves BC., Johnson GJ. 2004
Endothelial damage with cataract surgery techniques. Díaz-Valle D., Benítez del Castillo Sánchez JM., Castillo A., Sayagués O., Moriche M. 1998
Phacoemulsification versus extracapsular extraction: governmental costs. Kara-Jr N., Sirtoli MG., Santhiago MR., Parede TR., Espíndola RF., Carvalho Rde S. 2010
Functional assessment of two different accommodative intraocular lenses compared with a monofocal intraocular lens. Marchini G., Mora P., Pedrotti E., Manzotti F., Aldigeri R., Gandolfi SA. 2007
A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. Lima FE., Magacho L., Carvalho DM., Susanna R., Avila MP. 2004
Partial Tenon's capsule resection with adjunctive mitomycin C in Ahmed glaucoma valve implant surgery. Susanna R. 2003
Randomized comparison of 1-Site and 2-Site phacotrabeculectomy with 3-year follow-up. Cotran PR., Roh S., McGwin G. 2008
A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy. WuDunn D., Cantor LB., Palanca-Capistrano AM., Hoop J., Alvi NP., Finley C., Lakhani V., Burnstein A., Knotts SL. 2002
Fellow eye comparison between the 1CU accommodative intraocular lens and the Acrysof MA30 monofocal intraocular lens. Heatley CJ., Spalton DJ., Hancox J., Kumar A., Marshall J. 2005
Potential of the 1 CU accommodative intraocular lens. Sauder G., Degenring RF., Kamppeter B., Hugger P. 2005
Visual outcome of conventional extracapsular cataract extraction with posterior chamber intraocular lens implantation versus manual small-incision cataract surgery. Gurung A., Karki DB., Shrestha S., Rijal AP. -- Not Found --
Phaco-emulsification versus manual small-incision cataract surgery in South Africa. Cook C., Carrara H., Myer L. 2012
Prospective randomized comparative study of macular thickness following phacoemulsification and manual small incision cataract surgery. Ghosh S., Roy I., Biswas PN., Maji D., Mondal LK., Mukhopadhyay S., Bhaduri G. 2010
Comparison of endothelial cell loss after cataract surgery: phacoemulsification versus manual small-incision cataract surgery: six-week results of a randomized control trial. Gogate P., Ambardekar P., Kulkarni S., Deshpande R., Joshi S., Deshpande M. 2010
A prospective randomized clinical trial of phacoemulsification vs manual sutureless small-incision extracapsular cataract surgery in Nepal. Ruit S., Tabin G., Chang D., Bajracharya L., Kline DC., Richheimer W., Shrestha M., Paudyal G. 2007
Phacoemulsification versus small incision cataract surgery (SICS): which one is a better surgical option for immature cataract in developing countries? Singh SK., Winter I., Surin L. -- Not Found --
Phacoemulsification versus manual small-incision cataract surgery for white cataract. Venkatesh R., Tan CS., Sengupta S., Ravindran RD., Krishnan KT., Chang DF. 2010
Randomised clinical trial of lensectomy versus lens aspiration and primary capsulotomy for children with bilateral cataract in south India. Eckstein M., Vijayalakshmi P., Gilbert C., Foster A. 1999
Morphological and functional results of AcrySof intraocular lens implantation in children: prospective randomized study of age-related surgical management. Müllner-Eidenböck A., Amon M., Moser E., Kruger A., Abela C., Schlemmer Y., Zidek T. 2003
Posterior continuous curvilinear capsulorhexis with and without optic capture of the posterior chamber intraocular lens in the absence of vitrectomy. Raina UK., Gupta V., Arora R., Mehta DK. -- Not Found --
Necessity of vitrectomy when optic capture is performed in children older than 5 years. Vasavada AR., Trivedi RH., Singh R. 2001
Are routine preoperative medical tests needed with cataract surgery? Lira RP., Nascimento MA., Moreira-Filho DC., Kara-José N., Arieta CE. 2001
The value of routine preoperative medical testing before cataract surgery Schein OD., Katz J., Bass EB., Tielsch JM., Lubomski LH., Feldman MA., Petty BG., Steinberg EP. 2000
Quality of life evaluation after implantation of 2 multifocal intraocular lens models and a monofocal model. Alió JL., Plaza-Puche AB., Piñero DP., Amparo F., Rodríguez-Prats JL., Ayala MJ. 2011
One-year outcomes with new-generation multifocal intraocular lenses. Cillino S., Casuccio A., Di Pace F., Morreale R., Pillitteri F., Cillino G., Lodato G. 2008
Contrast sensitivity after implantation of diffractive bifocal and monofocal intraocular lenses. Haaskjold E., Allen ED., Burton RL., Webber SK., Sandvig KU., Jyrkkiö H., Leite E., Liekfeld A., Philipson B., Nyström A., Wollensak J. 1998
Comparing the 1CU accommodative, multifocal, and monofocal intraocular lenses: a randomized trial. Harman FE., Maling S., Kampougeris G., Langan L., Khan I., Lee N., Bloom PA. 2008
Cataract extraction with multifocal intraocular lens implantation: a multinational clinical trial evaluating clinical, functional, and quality-of-life outcomes. Javitt JC., Steinert RF. 2000
Comparison of the Binocular Vision Quality After Implantation of Monofocal and Multifocal Intraocular Lenses Vahid Jusufović, Dževdet Sarajlić, Jasmin Zvorničanin, Zlatko Mušanović, Meliha Halilbašić 2011
Contrast sensitivity and depth of focus with aspheric multifocal versus conventional monofocal intraocular lens. --, Dadeya S., Kaushik S. 2001
Prospective randomised double-masked trial of bilateral multifocal, bifocal or monofocal intraocular lenses. Leyland MD., Langan L., Goolfee F., Lee N., Bloom PA. 2002
Comparative performance of intraocular lenses in eyes with cataract and uveitis. Alió JL., Chipont E., BenEzra D., Fakhry MA. 2002
Biocompatibility and blood-aqueous barrier impairment in at-risk eyes with heparin-surface-modified or unmodified lenses. Mester U., Strauss M., Grewing R. 1998
Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis--a prospective randomized study. Roesel M., Heinz C., Heimes B., Koch JM., Heiligenhaus A. 2008
Heparin surface-modified intraocular lenses in patients with inactive uveitis or diabetes. Tabbara KF., Al-Kaff AS., Al-Rajhi AA., Al-Mansouri SM., Badr IA., Chavis PS., Al-Omar OM. 1998
Effect of diclofenac versus dexamethasone on posterior capsule opacification. Barequet IS., Wygnanski-Jaffe T., Sachs D. 2004
Effect of 1-piece and 3-piece AcrySof intraocular lenses on the development of posterior capsule opacification after cataract surgery. Bender LE., Nimsgern C., Jose R., Jayaram H., Spalton DJ., Tetz MR., Packard RB., Meacock W., Boyce J. 2004
Effect of anterior capsule polishing on the posterior capsule opacification-inhibiting properties of a sharp-edged, 3-piece, silicone intraocular lens: three- and 5-year results of a randomized trial. Bolz M., Menapace R., Findl O., Sacu S., Buehl W., Wirtitsch M., Leydolt C., Kriechbaum K. 2006
Effect of an acrylic intraocular lens with a sharp posterior optic edge on posterior capsule opacification. Buehl W., Findl O., Menapace R., Rainer G., Sacu S., Kiss B., Petternel V., Georgopoulos M. 2002
Effect of a silicone intraocular lens with a sharp posterior optic edge on posterior capsule opacification. Buehl W., Menapace R., Sacu S., Kriechbaum K., Koeppl C., Wirtitsch M., Georgopoulos M., Findl O. 2004
Long-term effect of optic edge design in an acrylic intraocular lens on posterior capsule opacification. Buehl W., Findl O., Menapace R., Sacu S., Kriechbaum K., Koeppl C., Wirtitsch M. 2005
Long-term effect of optic edge design in a silicone intraocular lens on posterior capsule opacification. Buehl W., Menapace R., Findl O., Neumayer T., Bolz M., Prinz A. 2007
Fellow-eye comparison of posterior capsule opacification with AcrySof SN60AT and AF-1 YA-60BB blue-blocking intraocular lenses. Hancox J., Spalton D., Cleary G., Boyce J., Nanavaty MA., Thyagarajan S., Marshall J. 2008
Inhibition of posterior capsule opacification with an immunotoxin specific for lens epithelial cells: 24 month clinical results. Clark DS., Emery JM., Munsell MF. 1998
Randomized intraindividual comparison of posterior capsule opacification between a microincision intraocular lens and a conventional intraocular lens. Cleary G., Spalton DJ., Hancox J., Boyce J., Marshall J. 2009
Long-term effect of sharp optic edges of a polymethyl methacrylate intraocular lens on posterior capsule opacification: a randomized trial. Findl O., Buehl W., Menapace R., Sacu S., Georgopoulos M., Rainer G. 2005
Effect of optic material on posterior capsule opacification in intraocular lenses with sharp-edge optics: randomized clinical trial. Findl O., Menapace R., Sacu S., Buehl W., Rainer G. 2005
Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation. Flach AJ., Dolan BJ. 2000
Fellow-eye comparison of posterior capsule opacification rates after implantation of 1CU accommodating and AcrySof MA30 monofocal intraocular lenses. Hancox J., Spalton D., Heatley C., Jayaram H., Yip J., Boyce J., Marshall J. 2007
Quantitative comparison of posterior capsule opacification after polymethylmethacrylate, silicone, and soft acrylic intraocular lens implantation. Hayashi H., Hayashi K., Nakao F., Hayashi F. 1998
Posterior capsule opacification after implantation of a hydrogel intraocular lens. Hayashi K., Hayashi H. 2004
Posterior capsule opacification in the presence of an intraocular lens with a sharp versus rounded optic edge. Hayashi K., Hayashi H. 2005
Influence on posterior capsule opacification and visual function of intraocular lens optic material. Hayashi K., Hayashi H. 2007
Comparison of posterior capsule opacification rates between hydrophilic and hydrophobic single-piece acrylic intraocular lenses. Heatley CJ., Spalton DJ., Kumar A., Jose R., Boyce J., Bender LE. 2005
Lens epithelial cell regression on the posterior capsule with different intraocular lens materials. Hollick EJ., Spalton DJ., Ursell PG., Pande MV. 1998
The effect of capsulorhexis size on posterior capsular opacification: one-year results of a randomized prospective trial. Hollick EJ., Spalton DJ., Meacock WR. 1999
Posterior capsular opacification with hydrogel, polymethylmethacrylate, and silicone intraocular lenses: two-year results of a randomized prospective trial. Hollick EJ., Spalton DJ., Ursell PG., Meacock WR., Barman SA., Boyce JF. 2000
Optic edge design as long-term factor for posterior capsular opacification rates. Kohnen T., Fabian E., Gerl R., Hunold W., Hütz W., Strobel J., Hoyer H., Mester U. 2008
Posterior capsule opacification after implantation of a hydrophilic or a hydrophobic acrylic intraocular lens: one-year follow-up. Kugelberg M., Wejde G., Jayaram H., Zetterström C. 2006
Posterior capsule opacification 3 years after implantation of an AcrySof and a MemoryLens in fellow eyes. Küçüksümer Y., Bayraktar S., Sahin S., Yilmaz OF. 2000
Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. Laurell CG., Zetterström C. 2002
Effectiveness of multifocal intraocular lenses to correct presbyopia after cataract surgery: a randomized controlled trial. Nijkamp MD., Dolders MG., de Brabander J., van den Borne B., Hendrikse F., Nuijts RM. 2004
Visual function with bilateral implantation of monofocal and multifocal intraocular lenses: a prospective, randomized, controlled clinical trial. Martínez Palmer A., Gómez Faiña P., España Albelda A., Comas Serrano M., Nahra Saad D., Castilla Céspedes M. 2008
Quality of vision after AMO Array multifocal intraocular lens implantation. Sen HN., Sarikkola AU., Uusitalo RJ., Laatikainen L. 2004
Visual function after monocular implantation of apodized diffractive multifocal or single-piece monofocal intraocular lens Randomized prospective comparison. Zhao G., Zhang J., Zhou Y., Hu L., Che C., Jiang N. 2010
Long-term effect of 1-piece and 3-piece hydrophobic acrylic intraocular lens on posterior capsule opacification: a randomized trial. Leydolt C., Davidovic S., Sacu S., Menapace R., Neumayer T., Prinz A., Buehl W., Findl O. 2007
Heparin eyedrops to prevent posterior capsule opacification. Mastropasqua L., Lobefalo L., Ciancaglini M., Ballone E., Gallenga PE. 1997
Double-masked prospective ocular safety study of a lens epithelial cell antibody to prevent posterior capsule opacification. Meacock WR., Spalton DJ., Hollick EJ., Boyce JF., Barman S., Sanguinetti G. 2000
Effect of intraocular lens haptic compressibility on the posterior lens capsule after cataract surgery. Meacock WR., Spalton DJ. 2001
Efficacy and safety of capsular bending ring implantation to prevent posterior capsule opacification: three-year results of a randomized clinical trial. Menapace R., Sacu S., Georgopoulos M., Findl O., Rainer G., Nishi O. 2008
Posterior capsule opacification after implantation of CeeOn Edge 911A, PhacoFlex SI-40NB, and AcrySof MA60BM lenses: one-year results of an intraindividual comparison multicenter study. Mester U., Fabian E., Gerl R., Hunold W., Hütz W., Strobel J., Hoyer H., Kohnen T. 2004
A prospective, randomised comparison of single and three piece acrylic foldable intraocular lenses. Nejima R., Miyata K., Honbou M., Tokunaga T., Tanabe T., Sato M., Oshika T. 2004
Prospective intrapatient comparison of 6.0-millimeter optic single-piece and 3-piece hydrophobic acrylic foldable intraocular lenses. Nejima R., Miyai T., Kataoka Y., Miyata K., Honbou M., Tokunaga T., Kawana K., Kiuchi T., Oshika T. 2006
Posterior capsule opacification after phacoemulsification: silicone CeeOn Edge versus acrylate AcrySof intraocular lens. Prosdocimo G., Tassinari G., Sala M., Di Biase A., Toschi PG., Gismondi M., Corbanese U. 2003
Long-term results of sealed capsule irrigation using distilled water to prevent posterior capsule opacification: a prospective clinical randomised trial. Rabsilber TM., Limberger IJ., Reuland AJ., Holzer MP., Auffarth GU. 2007
Comparison of posterior capsule opacification between the 1-piece and 3-piece Acrysof intraocular lenses: two-year results of a randomized trial. Sacu S., Findl O., Menapace R., Buehl W., Wirtitsch M. 2004
Effect of anterior capsule polishing on fibrotic capsule opacification: three-year results. Sacu S., Menapace R., Wirtitsch M., Buehl W., Rainer G., Findl O. 2004
Influence of optic edge design and anterior capsule polishing on posterior capsule fibrosis. Sacu S., Menapace R., Findl O., Georgopoulos M., Buehl W., Kriechbaum K., Rainer G. 2004
Effect of intraocular lens optic edge design and material on fibrotic capsule opacification and capsulorhexis contraction. Sacu S., Menapace R., Buehl W., Rainer G., Findl O. 2004
Long-term efficacy of adding a sharp posterior optic edge to a three-piece silicone intraocular lens on capsule opacification: five-year results of a randomized study. Sacu S., Menapace R., Findl O., Kiss B., Buehl W., Georgopoulos M. 2005
Effect of intraocular lens edge profile on posterior capsule opacification after extracapsular cataract surgery in a developing country. Shah A., Spalton DJ., Gilbert C., Vasavada A., Boyce JF., Minassian D., Jayaram H., Mabey D. 2007
Posterior capsule opacification after extra capsular cataract extraction in Indian rural population: foldable acrylic vs poly (methyl-methacrylate) intraocular lenses a randomized clinical trial. Shah AR., Praveen MR., Vasavada AR. 2008
Three-year follow-up of posterior capsule opacification with two different silicone intraocular lenses. Sundelin K., Shams H., Stenevi U. 2005
Three-year prospective randomized study of incidence of posterior capsule opacification in eyes treated with topical diclofenac and betamethasone. Tsuchiya T., Ayaki M., Onishi T., Kageyama T., Yaguchi S. 2003
Anterior capsule relationship of the AcrySof intraocular lens optic and posterior capsule opacification: a prospective randomized clinical trial. Vasavada AR., Raj SM. 2004
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. -- Not Found -- 1999
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. -- Not Found -- 2001
The age-related macular degeneration radiotherapy trial (AMDRT): one year results from a pilot study. Marcus DM., Peskin E., Maguire M., Weissgold D., Alexander J., Fine S., Followill D. 2004
Randomized trial of radiation for age-related macular degeneration. Char DH., Irvine AI., Posner MD., Quivey J., Phillips TL., Kroll S. 1999
Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial. Ciulla TA., Danis RP., Klein SB., Malinovsky VE., Soni PS., Pratt LM., Pugh NO., Morphis JG., Bloch C., Cameron J. 2002
Radiotherapy for age-related macular degeneration: is there a benefit for classic CNV? Eter N., Schüller H., Spitznas M. 2001
Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study. Jaakkola A., Heikkonen J., Tommila P., Laatikainen L., Immonen I. 2005
Age-related macular degeneration: long-term results of radiotherapy for subfoveal neovascular membranes. Kobayashi H., Kobayashi K. 2000
External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial. Marcus DM., Sheils W., Johnson MH., McIntosh SB., Leibach DB., Maguire A., Alexander J., Samy CN. 2001
A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration. -- Not Found -- 1999
Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Hart PM., Chakravarthy U., Mackenzie G., Chisholm IH., Bird AC., Stevenson MR., Owens SL., Hall V., Houston RF., McCulloch DW., Plowman N. 2002
Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial. Valmaggia C., Ries G., Ballinari P. 2002
Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration. Guymer RH., Baird PN., Varsamidis M., Busija L., Dimitrov PN., Aung KZ., Makeyeva GA., Richardson AJ., Lim L., Robman LD. 2013
Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Gelisken F., Voelker M., Schwabe R., Besch D., Aisenbrey S., Szurman P., Grisanti S., Herzau V., Bartz-Schmidt KU. 2007
Digital retroilluminated photography to analyze posterior capsule opacification in eyes with intraocular lenses. Wang MC., Woung LC. 2000
Posterior capsule opacification: comparison of 3 intraocular lenses of different materials and design. Wejde G., Kugelberg M., Zetterström C. 2003
Position of anterior capsulorhexis and posterior capsule opacification. Wejde G., Kugelberg M., Zetterström C. 2004
Factors influencing the formation of posterior capsular opacities after extracapsular cataract extraction with posterior chamber lens implant. Westling AK., Calissendorff BM. 1991
Posterior capsule opacification and neodymium: YAG capsulotomy with heparin-surface-modified intraocular lenses. Winther-Nielson A., Johansen J., Pedersen GK., Corydon L. 1998
Posterior capsule opacification after phacoemulsification in patients with postoperative steroidal and nonsteroidal treatment. Zaczek A., Laurell CG., Zetterström C. 2004
Influence of three-piece and single-piece designs of two sharp-edge optic hydrophobic acrylic intraocular lenses on the prevention of posterior capsule opacification: a prospective, randomised, long-term clinical trial. Zemaitiene R., Jasinskas V., Auffarth GU. 2007
Combined phacoemulsification and filtering surgery with the 'no-stitch' technique. Anders N., Pham T., Holschbach A., Wollensak J. 1997
Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. Fea AM. 2010
Fluorophotometric study of the effect of the glaukos trabecular microbypass stent on aqueous humor dynamics. Fernández-Barrientos Y., García-Feijoó J., Martínez-de-la-Casa JM., Pablo LE., Fernández-Pérez C., García Sánchez J. 2010
Combined clear cornea phacoemulsification and trabecular aspiration in the treatment of pseudoexfoliative glaucoma associated with cataract. Georgopoulos GT., Chalkiadakis J., Livir-Rallatos G., Theodossiadis PG., Theodossiadis GP. 2000
Intraocular pressure response to combined phacoemulsification and trabeculotomy ab externo versus phacoemulsification alone in primary open-angle glaucoma. Gimbel HV., Meyer D., DeBroff BM., Roux CW., Ferensowicz M. 1995
Comparative study of trabecular aspiration vs trabeculectomy in glaucoma triple procedure to treat pseudoexfoliation glaucoma. Jacobi PC., Dietlein TS., Krieglstein GK. 1999
Phaco-trabeculectomy in controlled, advanced, open-angle glaucoma and cataract: parallel, randomized clinical study of efficacy and safety. Liaska A., Papaconstantinou D., Georgalas I., Koutsandrea C., Theodosiadis P., Chatzistefanou K. 2014
Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Samuelson TW., Katz LJ., Wells JM., Duh YJ., Giamporcaro JE. 2011
A prospective study of combined phacoemulsification-trabeculectomy versus conventional phacoemulsification in cataract patients with coexisting open angle glaucoma. Storr-Paulsen A., Pedersen JH., Laugesen C. 1998
Randomized, controlled study of low-dose 5-fluorouracil in primary trabeculectomy. Chaudhry IA., Pasha MA., O'Connor DJ., Weitzman ML., Caprioli J. 2000
Fluorouracil Filtering Surgery Study one-year follow-up. The Fluorouracil Filtering Surgery Study Group. -- Not Found -- 1989
Single intraoperative application of 5-Fluorouracil versus placebo in low-risk trabeculectomy surgery: a randomized trial. Leyland M., Bloom P., Zinicola E., McAlister J., Rassam S., Migdal C. 2001
Trabeculectomy, phacoemulsification, and posterior chamber lens implantation with and without 5-fluorouracil. O'Grady JM., Juzych MS., Shin DH., Lemon LC., Swendris RP. 1993
Postoperative systemic corticosteroid treatment and Molteno implant surgery: a randomized clinical trial. Välimäki J., Airaksinen PJ., Tuulonen A., Risteli J. 1999
Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Wilson MR., Mendis U., Smith SD., Paliwal A. 2000
Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy. Wilson MR., Mendis U., Paliwal A., Haynatzka V. 2003
A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Krupin T., Liebmann JM., Greenfield DS., Ritch R., Gardiner S. 2011
Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial. Gray TA., Fenerty C., Harper R., Spencer AF., Campbell M., Henson DB., Waterman H. 2012
Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring. Hermann MM., Papaconstantinou D., Muether PS., Georgopoulos G., Diestelhorst M. 2011
Comparison of the double-plate Molteno drainage implant with the Schocket procedure. Smith MF., Sherwood MB., McGorray SP. 1992
Needling versus medical treatment in encapsulated blebs. A randomized, prospective study. Costa VP., Correa MM., Kara-Jose N. 1997
Amniotic membrane transplantation for repair of leaking glaucoma filtering blebs. Budenz DL., Barton K., Tseng SC. 2000
Randomized clinical trial of the 350-mm2 versus the 500-mm2 Baerveldt implant: longer term results: is bigger better? Britt MT., LaBree LD., Lloyd MA., Minckler DS., Heuer DK., Baerveldt G., Varma R. 1999
Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial. Costa VP., Azuara-Blanco A., Netland PA., Lesk MR., Arcieri ES. 2004
A comparison of postoperative complications from pressure-ridge Molteno implants versus Molteno implants with suture ligation. Gerber SL., Cantor LB., Sponsel WE. 1997
A randomized study of trabeculectomy and subconjunctival administration of fluorouracil in primary glaucomas. Ophir A., Ticho U. 1992
A randomized study of 5-fluorouracil and filtration surgery. Ruderman JM., Welch DB., Smith MF., Shoch DE. 1987
5-Fluorouracil after primary combined filtration surgery. Wong PC., Ruderman JM., Krupin T., Goldenfeld M., Rosenberg LF., Shields MB., Ritch R., Liebmann JM., Gieser DK. 1994
The effect of surface area expansion with pericardial membrane (preclude) in Ahmed glaucoma valve implant surgery. Hwang JM., Kee C. 2004
Prevention of early postoperative hypotony by partial ligation of silicone tube in Ahmed glaucoma valve implantation. Kee C. 2001
A randomised trial of the effect of intraoperative 5-FU on the outcome of trabeculectomy in east Africa. Yorston D., Khaw PT. 2001
Trabeculectomy with mitomycin. A comparative study with fluorouracil. Kitazawa Y., Kawase K., Matsushita H., Minobe M. 1991
5-Fluorouracil and mitomycin C in pseudophakic patients. Lamping KA., Belkin JK. 1995
Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial. Mostafaei A. 2011
Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Singh K., Egbert PR., Byrd S., Budenz DL., Williams AS., Decker JH., Dadzie P. 1997
Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Singh K., Mehta K., Shaikh NM., Tsai JC., Moster MR., Budenz DL., Greenfield DS., Chen PP., Cohen JS., Baerveldt GS., Shaikh S. 2000
The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up. Sisto D., Vetrugno M., Trabucco T., Cantatore F., Ruggeri G., Sborgia C. 2007
Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C. Cillino S., Di Pace F., Casuccio A., Lodato G. 2005
Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. El Sayyad F., Helal M., El-Kholify H., Khalil M., El-Maghraby A. 2000
A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma. Kobayashi H., Kobayashi K., Okinami S. 2003
Nonpenetrating deep sclerectomy with reticulated hyaluronic acid implant versus punch trabeculectomy: a prospective clinical trial. Russo V., Scott IU., Stella A., Balducci F., Cosma A., Barone A., Delle Noci N. 2008
Primary viscocanalostomy versus trabeculectomy for primary open-angle glaucoma: three-year prospective randomized clinical trial. Yalvac IS., Sahin M., Eksioglu U., Midillioglu IK., Aslan BS., Duman S. 2004
Effect of a YAG laser iridotomy on intraocular pressure in pigment dispersion syndrome. Gandolfi SA., Vecchi M. 1996
YAG laser peripheral iridotomy for the prevention of pigment dispersion glaucoma a prospective, randomized, controlled trial. Scott A., Kotecha A., Bunce C., Balidis M., Garway-Heath DF., Miller MH., Wormald R. 2011
Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial. Glanz K., Beck AD., Bundy L., Primo S., Lynn MJ., Cleveland J., Wold JA., Echt KV. 2012
Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life. Laibovitz R., Boyle J., Snyder E., Strohmaier K., Adamsons I. 1996
The influence of health literacy level on an educational intervention to improve glaucoma medication adherence. Muir KW., Ventura A., Stinnett SS., Enfiedjian A., Allingham RR., Lee PP. 2012
Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial. Nakakura S., Tabuchi H., Baba Y., Maruiwa F., Ando N., Kanamoto T., Kiuchi Y. 2012
Improving medication compliance: a randomised clinical trial. Norell SE. 1979
Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients. Sakai H., Shinjyo S., Nakamura Y., Nakamura Y., Ishikawa S., Sawaguchi S. 2005
Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma. Schenker H., Maloney S., Liss C., Gormley G., Hartenbaum D. 1999
The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group. Sverrisson T., Gross R., Pearson J., Rusk C., Adamsons I. 1999
Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma. Collignon-Brach J. 1994
Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Katz GJ., Higginbotham EJ., Lichter PR., Skuta GL., Musch DC., Bergstrom TJ., Johnson AT. 1995
A comparison of the effects of betaxolol, timolol, and pilocarpine on visual function in patients with open-angle glaucoma. Drance SM. 1998
Results of the European Glaucoma Prevention Study. Miglior S., Zeyen T., Pfeiffer N., Cunha-Vaz J., Torri V., Adamsons I. 2005
Influence of carteolol and timolol on IOP an visual fields in glaucoma: a multi-center, double-masked, prospective study. Flammer J., Kitazawa Y., Bonomi L., Mills B., Fsadni M., Dorigo MT., Shirato S., Journel B., Chavy B., Chevallier B. -- Not Found --
Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial. Heijl A., Bengtsson B. 2000
Longterm visual field follow-up of glaucoma patients treated with beta-blockers. Kaiser HJ., Flammer J., Stümpfig D., Hendrickson P. 1994
Results of the betaxolol versus placebo treatment trial in ocular hypertension. Kamal D., Garway-Heath D., Ruben S., O'Sullivan F., Bunce C., Viswanathan A., Franks W., Hitchings R. 2003
Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial. Kass MA. 1989
Argon laser trabeculoplasty in primary open-angle glaucoma--results in black Jamaican population. Moriarty BJ., Char JN., Acheson RW., Dunn DT. 1988
Peripheral anterior synechiae formation after trabeculoplasty. Rouhiainen HJ., Teräsvirta ME., Tuovinen EJ. 1988
Laser trabeculoplasty as supplementary treatment for primary open angle glaucoma. Sherwood MB., Lattimer J., Hitchings RA. 1987
Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2. LeBlanc RP. 1998
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Kass MA., Heuer DK., Higginbotham EJ., Johnson CA., Keltner JL., Miller JP., Parrish RK., Wilson MR., Gordon MO. 2002
A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group. Schuman JS., Horwitz B., Choplin NT., David R., Albracht D., Chen K. 1997
Ocular hypertension: correlation of anterior chamber angle width and risk of progression to glaucoma. Wishart PK., Batterbury M. 1992
A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma. Watson PG., Barnett MF., Parker V., Haybittle J. 2001
Comparison of the effects of brimonidine 0.2% and timolol 0.5% on retinal nerve fiber layer thickness in ocular hypertensive patients: a prospective, unmasked study. Tsai JC., Chang HW. 2005
Decrease of optic disc cupping and pallor of ocular hypertensives with timolol therapy. Schwartz B., Lavin P., Takamoto T., Araujo DF., Smits G. 1995
Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Lichter PR., Musch DC., Gillespie BW., Guire KE., Janz NK., Wren PA., Mills RP. 2001
Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring. Hermann MM., Bron AM., Creuzot-Garcher CP., Diestelhorst M. 2011
Early trabeculectomy versus conventional management in primary open angle glaucoma. Jay JL., Murray SB. 1988
A comparison between medical and surgical treatment of glaucoma simplex--results of a prospective study. Smith R. 1968
Influence of treatment protocol on the long-term efficacy of argon laser trabeculoplasty. Grayson DK., Ritch R., Camras C., Lustgarten JS., Podos SM. 1993
Bronchial reactivity in healthy individuals undergoing long-term topical treatment with beta-blockers. Gandolfi SA., Chetta A., Cimino L., Mora P., Sangermani C., Tardini MG. 2005
Fornix-based versus limbal-based conjunctival flaps in initial trabeculectomy with postoperative 5-fluorouracil: four-year follow-up findings. el Sayyad F., el-Rashood A., Helal M., Hisham M., el-Maghraby A. 1999
Limbus-based versus Fornix-based conjunctival flap in filtering surgery. A randomized prospective study. Grehn F., Mauthe S., Pfeiffer N. 1989
Comparative results of limbal based versus fornix based conjunctival flaps for trabeculectomy. Khan AM., Jilani FA. -- Not Found --
Two-site phacotrabeculectomy with intraoperative mitomycin-C: fornix- versus limbus-based conjunctival opening in fellow eyes. Kozobolis VP., Siganos CS., Christodoulakis EV., Lazarov NP., Koutentaki MG., Pallikaris IG. 2002
Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. Lemon LC., Shin DH., Kim C., Bendel RE., Hughes BA., Juzych MS. 1998
Ranibizumab versus mitomycin C in primary trabeculectomy--a pilot study. Pro MJ., Freidl KB., Neylan CJ., Sawchyn AK., Wizov SS., Moster MR. 2015
Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy. Nilforushan N., Yadgari M., Kish SK., Nassiri N. 2012
Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study. Akkan JU., Cilsim S. 2015
Laser peripheral iridotomy with and without iridoplasty for primary angle-closure glaucoma: 1-year results of a randomized pilot study. Sun X., Liang YB., Wang NL., Fan SJ., Sun LP., Li SZ., Liu WR. 2010
The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. -- Not Found -- 2002
Diode laser trabeculoplasty versus argon laser trabeculoplasty in the control of primary open angle glaucoma. Blyth CP., Moriarty AP., McHugh JD. 1999
Diode laser compared with argon laser for trabeculoplasty. Brancato R., Carassa R., Trabucchi G. 1991
Five-year results of a randomized, prospective, clinical trial of diode vs argon laser trabeculoplasty for open-angle glaucoma. Chung PY., Schuman JS., Netland PA., Lloyd-Muhammad RA., Jacobs DS. 1998
Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. Damji KF., Shah KC., Rock WJ., Bains HS., Hodge WG. 1999
Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Heijl A., Leske MC., Bengtsson B., Hyman L., Bengtsson B., Hussein M. 2002
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma. Sedghipour MR., Mostafaei A., Taghavi Y. 2011
Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial. Sengupta S., Venkatesh R., Ravindran RD. 2012
Intraocular pressure-lowering effect of auricular acupressure in patients with glaucoma: a prospective, single-blinded, randomized controlled trial. Her JS., Liu PL., Cheng NC., Hung HC., Huang PH., Chen YL., Lin CP., Lee CH., Chiu CC., Yu JS., Wang HS., Lee YJ., Shen JL., Chen WC., Chen YH. 2010
Beta radiation as an adjunct to low-risk trabeculectomy. Barnes RM., Mora JS., Best SJ. 2000
Effect of beta radiation on success of glaucoma drainage surgery in South Africa: randomised controlled trial. Kirwan JF., Cousens S., Venter L., Cook C., Stulting A., Roux P., Murdoch I. 2006
Randomized controlled clinical trial of beta irradiation as an adjunct to trabeculectomy in open-angle glaucoma. Rehman SU., Amoaku WM., Doran RM., Menage MJ., Morrell AJ. 2002
Low-dose mitomycin C trabeculectomy in patients with advanced glaucoma. Costa VP., Comegno PE., Vasconcelos JP., Malta RF., José NK. 1996
A long-term dose-response study of mitomycin in glaucoma filtration surgery. Robin AL., Ramakrishnan R., Krishnadas R., Smith SD., Katz JD., Selvaraj S., Skuta GL., Bhatnagar R. 1997
Adjunctive subconjunctival mitomycin C in glaucoma triple procedure. Shin DH., Simone PA., Song MS., Reed SY., Juzych MS., Kim C., Hughes BA. 1995
The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedure. Shin DH., Kim YY., Sheth N., Ren J., Shah M., Kim C., Yang KJ. 1998
A fluorophotometric study of corneal endothelium after trabeculectomy using different concentrations of Mitomycin-C. Szymanski A., Gierek-Lapinska A., Koziak M., Gierek-Ciaciura S. 1996
Macular degeneration treatment at Clatterbridge Centre for oncology: treatment and preliminary results Kacperek A, Briggs M, Sheen MA, Damato BE, Errington RD, Hardy S 2000
An evaluation of the effectiveness of a nurse-led glaucoma monitoring clinic Sheppard J, Warner J, Kelly K 2003
Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Modarres M., Nazari H., Falavarjani KG., Naseripour M., Hashemi M., Parvaresh MM. -- Not Found --
Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: a two-year trial. Chase HP., Garg SK., Harris S., Hoops S., Jackson WE., Holmes DL. 1993
Hospitalization and cataract surgery. Galin MA., Boniuk V., Obstbaum SA., Barasch KR., Baras I. 1981
Impact of preoperative testing on ophthalmologic and systemic outcomes in cataract surgery. Cavallini GM., Saccarola P., D'Amico R., Gasparin A., Campi L. -- Not Found --
The effects of three-piece or single-piece acrylic intraocular lens implantation on posterior capsule opacification. Bilge AH., Aykan U., Akin T., Unsal U. 2004
Posterior capsular opacification in pseudophakic eyes with a silicone or acrylic intraocular lens. Pohjalainen T., Vesti E., Uusitalo RJ., Laatikainen L. 2002
Argon laser trabeculoplasty with standard and long duration. Hugkulstone CE. 1990
The immediate pressure response to primary laser trabeculoplasty--a comparison of one- and two-stage treatment. Elsås T., Johnsen H., Brevik TA. 1989
Primary argon laser trabeculoplasty vs. pilocarpine. Short-term effects. Bergeå B., Svedbergh B. 1992
A comparative clinical trial of mitomycin C and cyclosporin A in trabeculectomy. Turaçli E., Gündüz K., Aktan G., Tamer C. 1996
Low-dosage mitomycin C as an adjunct to trabeculectomy. A prospective controlled study. Martini E., Laffi GL., Sprovieri C., Scorolli L. 1997
Levobunolol compared with timolol for the control of elevated intraocular pressure. Geyer O., Lazar M., Novack GD., Lue JC., Duzman E. 1986
Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma. Collignon-Brach J. 1992
Comparison of the ocular effects of three beta-blockers: Timolol, carteolol, and betaxolol Fama F, Santamaria S 1996
The effect of capsulorhexis size on development of posterior capsule opacification: small (4.5 to 5.0 mm) versus large (6.0 to 7.0 mm). Aykan U., Bilge AH., Karadayi K., Akin T. 2003
Static perimetry evaluation of argon green and dye laser treatment for choroidal neovascular membranes Duch Mestres F, Vilaplana D, Civit JR, Torres F, Barraquer J 1993
Visaline in the treatment of age-related macular degeneration: a pilot study. Kaiser HJ., Flammer J., Stümpfig D., Hendrickson P. 1995
A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen. Little HL., Showman JM., Brown BW. 1997
Multifocal versus monofocal intraocular lenses. Visual and refractive comparisons. el-Maghraby A., Marzouky A., Gazayerli E., Van der Karr M., DeLuca M. 1992
Prospectively randomized trial comparing the pseudoaccommodation of the AMO ARRAY multifocal lens and a monofocal lens. Percival SP., Setty SS. 1993
Performance of diffractive multifocal intraocular lenses in extracapsular cataract surgery. Rossetti L., Carraro F., Rovati M., Orzalesi N. 1994
A prospective, randomized, double-masked comparison of a zonal-progressive multifocal intraocular lens and a monofocal intraocular lens. Steinert RF., Post CT., Brint SF., Fritch CD., Hall DL., Wilder LW., Fine IH., Lichtenstein SB., Masket S., Casebeer C. 1992
Multicenter ophthalmic and nutritional age-related macular degeneration study--part 2: antioxidant intervention and conclusions. Richer S. 1996
Effect of posterior chamber intraocular lens design and surgical placement on postoperative outcome. Martin RG., Sanders DR., Souchek J., Raanan MG., DeLuca M. 1992
Silicone versus polymethylmethacrylate intraocular lenses with regard to capsular opacification. Olson RJ., Crandall AS. 1998
Clinical evaluation of posterior capsule opacification in eyes with different small-incision intraocular lenses. Yoshida S., Senoo T., Fujikake F., Obara Y. 2002
Combined phacoemulsification and filtering surgery with the 'no-stitch' technique. Anders N., Pham T., Holschbach A., Wollensak J. 1997
5-Fluorouracil in initial trabeculectomy. A prospective, randomized, multicenter study. Goldenfeld M., Krupin T., Ruderman JM., Wong PC., Rosenberg LF., Ritch R., Liebmann JM., Gieser DK. 1994
Which is better? One or two? A randomized clinical trial of single-plate versus double-plate Molteno implantation for glaucomas in aphakia and pseudophakia. Heuer DK., Lloyd MA., Abrams DA., Baerveldt G., Minckler DS., Lee MB., Martone JF. 1992
Aqueous shunts. Molteno versus Schocket. Wilson RP., Cantor L., Katz LJ., Schmidt CM., Steinmann WC., Allee S. 1992
The effect of a medication alarm device on patient compliance with topical pilocarpine. Laster SF., Martin JL., Fleming JB. 1996
A clinical trial of timolol and epinephrine in the treatment of primary open-angle glaucoma. Alexander DW., Berson FG., Epstein DL. 1988
A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Epstein DL., Krug JH., Hertzmark E., Remis LL., Edelstein DJ. 1989
Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group. -- Not Found -- 1989
A comparison of treated and untreated glaucoma suspects. Schulzer M., Drance SM., Douglas GR. 1991
Effect of timolol versus pilocarpine on visual field progression in patients with primary open-angle glaucoma. Vogel R., Crick RP., Mills KB., Reynolds PM., Sass W., Clineschmidt CM., Tipping R. 1992
Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Migdal C., Gregory W., Hitchings R. 1994
A randomized study of mitomycin augmentation in combined phacoemulsification and trabeculectomy. Carlson DW., Alward WL., Barad JP., Zimmerman MB., Carney BL. 1997
A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Cohen JS., Greff LJ., Novack GD., Wind BE. 1996
The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group. -- Not Found -- 1990
Argon laser trabeculoplasty: comparison of bichromatic and monochromatic wavelengths. Smith J. 1984
Argon laser trabeculoplasty or trabeculectomy a prospective randomised block study. Watson PG., Allen ED., Graham CM., Porter GP., Pickering MS. 1985




Creative Commons LicenseThis graphic notice indicates that you are leaving this Federal Government Web site and entering a non-Federal Web site. Creative Commons  
The data contained in this project are distributed under the terms of the Creative Commons Attribution-NonCommerical license, which permits the use, dissemination, and reproduction in any medium, provided the original work is properly cited, and that the use is non-commercial and otherwise in compliance with the license. See: https://creativecommons.org/licenses/by-nc/3.0/